Gene · 8784
Papers4,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 4,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| T-cell exhaustion and stemness in antitumor immunity: Characteristics, mechanisms, and implications. | Front Immunol | 2023 | 36891319 | PubTator, text mining | PubMed |
| What do we know about co-stimulatory and co-inhibitory immune checkpoint signals in ankylosing spondylitis? | Clin Exp Immunol | 2023 | 36883249 | PubTator, text mining | PubMed |
| Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers. | Front Immunol | 2023 | 36875063 | PubTator, text mining | PubMed |
| Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approach. | Cancer Immunol Immunother | 2023 | 36869232 | PubTator, text mining | PubMed |
| Pharmacodynamic activity of BMS-986156, a glucocorticoid-induced TNF receptor-related protein agonist, alone or in combination with nivolumab in patients with advanced solid tumors. | ESMO Open | 2023 | 36863094 | PubTator, text mining | PubMed |
| Spatial multi-omics revealed the impact of tumor ecosystem heterogeneity on immunotherapy efficacy in patients with advanced non-small cell lung cancer treated with bispecific antibody. | J Immunother Cancer | 2023 | 36854570 | PubTator, text mining | PubMed |
| LRP2 and DOCK8 Are Potential Antigens for mRNA Vaccine Development in Immunologically 'Cold' KIRC Tumours. | Vaccines (Basel) | 2023 | 36851274 | PubTator, text mining | PubMed |
| Construction of a prognostic prediction model for renal clear cell carcinoma combining clinical traits. | Sci Rep | 2023 | 36849551 | PubTator, text mining | PubMed |
| Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment. | Bone Res | 2023 | 36849442 | PubTator, text mining | PubMed |
| Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma. | Front Immunol | 2023 | 36845131 | PubTator, text mining | PubMed |
| Acquisition of Immune Privilege in GBM Tumors: Role of Prostaglandins and Bile Salts. | Int J Mol Sci | 2023 | 36834607 | PubTator, text mining | PubMed |
| Salivary Diagnostics in Pediatrics and the Status of Saliva-Based Biosensors. | Biosensors (Basel) | 2023 | 36831972 | PubTator, text mining | PubMed |
| Targets of Immune Escape Mechanisms in Cancer: Basis for Development and Evolution of Cancer Immune Checkpoint Inhibitors. | Biology (Basel) | 2023 | 36829496 | PubTator, text mining | PubMed |
| Treg-selective IL-2 starvation synergizes with CD40 activation to sustain durable responses in lymphoma models. | J Immunother Cancer | 2023 | 36822670 | PubTator, text mining | PubMed |
| Landscape of costimulatory molecule signature in breast cancer and its prognostic significance. | Ann Transl Med | 2023 | 36819560 | PubTator, text mining | PubMed |
| Immunotherapy in cervical cancer: From the view of scientometric analysis and clinical trials. | Front Immunol | 2023 | 36817443 | PubTator, text mining | PubMed |
| Highly expressed CENPL is correlated with breast cancer cell proliferation and immune infiltration. | Front Oncol | 2023 | 36816951 | PubTator, text mining | PubMed |
| Breast cancer tumor microenvironment affects Treg/IL-17-producing Treg/Th17 cell axis: Molecular and therapeutic perspectives. | Mol Ther Oncolytics | 2023 | 36816749 | PubTator, text mining | PubMed |
| Prognosis and personalized medicine prediction by integrated whole exome and transcriptome sequencing of hepatocellular carcinoma. | Front Genet | 2023 | 36816040 | PubTator, text mining | PubMed |
| Immunogenic Cell Death in Hematological Malignancy Therapy. | Adv Sci (Weinh) | 2023 | 36815385 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8784/papers?page=33